AvePoint Insider Sale: 35,000 Shares Disposed Under 10b5-1 Plan

Rhea-AI Filing Summary

AvePoint, Inc. insider sale of 35,000 common shares executed under a Rule 10b5-1 plan. The reporting person, Brian Michael Brown, who serves as Chief Legal Officer and a director, reported three sales totaling 35,000 shares on 09/23/2025 at prices between $15.49 and $15.59 per share. Following these transactions the filing shows beneficial ownership reported in the ranges of 650,474 down to 633,741 shares across the reported lines, which the filer states includes both non-RSU common stock and aggregate vested and unvested RSUs subject to previously reported vesting schedules. The filing notes the sales were made pursuant to a 10b5-1 trading plan adopted December 18, 2024.

Positive

• Sales executed under a Rule 10b5-1 plan, indicating the trades were prearranged and reducing appearance of opportunistic timing
• Substantial retained ownership after sales (reported ~633,741 shares), suggesting continued insider alignment with shareholders
• Disclosure clarifies holdings include vested and unvested RSUs, improving transparency about the composition of beneficial ownership

Negative

• Insider disposed of 35,000 shares, which reduces the reporting person’s position and could be viewed negatively by some investors
• Multiple sale prices reported ($15.49–$15.59), indicating the sales occurred across different executions rather than a single block

Insights

Financial Analyst

TL;DR: Insider sold 35,000 shares under a pre-established 10b5-1 plan; ownership remains substantial at ~633k shares.

The transactions are routine insider sales executed under a Rule 10b5-1 trading plan, which reduces the risk that these trades reflect nonpublic information. The total sale size of 35,000 shares at prices between $15.49 and $15.59 generated proceeds in the mid-six-figures. Reported beneficial ownership after the sales remains large—reported amounts of 650,474, 634,420, and 633,741 across the disclosure lines—and include vested and unvested RSUs per the filer, indicating continued alignment with shareholder interests. From a market-impact perspective, the size is unlikely to be material relative to a typical public float unless the company has a very small market capitalization.

Corporate Governance Expert

TL;DR: Sale follows a documented prearranged plan, consistent with governance best practices for insiders

The use of a 10b5-1 plan, adopted on December 18, 2024, and the explicit explanation in the Form 4 support governance transparency and compliance with insider trading rules. The filer discloses that reported post-transaction holdings include non-RSU common stock and both vested and unvested RSUs tied to prior vesting schedules, which helps clarify the composition of ownership. No notifications of policy breaches or unusual derivative activity appear in the filing. Overall, this is a routine disclosure that aligns with expected governance procedures for executive stock dispositions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Brown Brian Michael

(Last) (First) (Middle)

C/O AVEPOINT, INC.

901 E BYRD ST, SUITE 900

(Street)

RICHMOND VA 23219

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/23/2025		S		18,267(1)	D	$15.59	650,474(2)	D
Common Stock	09/23/2025		S		16,054(1)	D	$15.53	634,420(2)	D
Common Stock	09/23/2025		S		679(1)	D	$15.49	633,741(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2024.

2. Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024 and March 18, 2025.

	/s/ Brian Michael Brown	09/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the AVPT Form 4 report?

The Form 4 reports that Brian Michael Brown sold a total of 35,000 shares of AvePoint common stock under a Rule 10b5-1 plan.

How many shares did the insider own after the reported transactions?

The filing shows reported beneficial ownership figures of 650,474, 634,420, and 633,741 across the reported lines, which include non-RSU common stock and vested and unvested RSUs.

At what prices were the AVPT shares sold?

The reported sale prices ranged from $15.49 to $15.59 per share.

Were the sales part of a prearranged trading plan?

Yes. The filer states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2024.

What is the reporting person's role at AVPT?

The reporting person, Brian Michael Brown, is listed as a Director and the company's Chief Legal Officer.

Does the Form 4 disclose any derivative transactions?

No. Table II for derivative securities in the filing contains no reported transactions.